Legal Opinion
Newman v. Novartis Pharmaceuticals Corp.
District Court, E.D. New York
Decided October 3, 2014No. 06-CV-431 (ADS)(WDW)PublishedCited by 2 opinions
1Opinion of the Court
MEMORANDUM OF DECISION AND ORDER
SPATT, District Judge.
On February 1, 2006, Barbara Davids (“Davids”) initiated this action against Novartis Pharmaceuticals Corporation (“Novartis” or the “Defendant”), alleging that the Defendant’s drug Zometa caused her to develop a condition referred to as bis-phosphonate-related osteonecrosis of the jaw (“BRONJ”). In this regard, Davids brought causes of action for (1) strict products liability; (2) breach of implied warranty; and (3) negligence. On October 4, 2012, a jury trial was commenced and approximately one month later, on November 2, 2012, the jury…
2Cases cited14 opinions
- Schwartz v. Liberty Mutual InsuranceCourt of Appeals for the Second Circuit · 2008
- Ward v. ZelikovskySupreme Court of New Jersey · 1994
- NML Capital v. Republic of ArgentinaNew York Court of Appeals · 2011
- Rohring v. City of Niagara FallsNew York Court of Appeals · 1994
- Belinski v. GoodmanNew Jersey Superior Court Appellate Division · 1976
9 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Concord General Mutual Insurance Company and Kevin Flanagan and Linda Flanagan v. Nathan Gritman, Austin Lawson, Nicholas T. Sweet, Elizabeth Plude, Kevin Spear and Dylan StinsonSupreme Court of Vermont · 2016
- Concord General Mutual Insurance Company and Kevin Flanagan and Linda Flanagan v. Nathan Gritman, Austin Lawson, Nicholas T. Sweet, Elizabeth Plude, Kevin Spear and Dylan StinsonSupreme Court of Vermont · 2016